Log in
Log in
Secretary of State Home
VT Re-tain
Secretary of State Home
VT Re-tain
search archive
Browse
Back
VT Re-tain
Search
+
Filter
Agency
Domain
Activity
Record Type
Person(s)
Administration
Year
Jurisdiction
Legislative Session
No.
Preserve365 Person(s)
matches
between
and
Submit
S.216
Object Type: Folder
In Folder:
Bills
Browse Archive
>
. . .
>
Bills
>
S.216
Sort by Type
Sort by Title
Sort by ID
Sort by Type
▲
Button group show selection as: List
Active view
VT Re-tain
Folder
Title
▲
▼
ID
▲
▼
Type
▲
▼
S.216~Cory Gustafson~Vermont Single Formulary -S.216 Written Testimony~2-23-2016.pdf
S.216~Jamie Feehan~S.216 CVS Health Written Testimony~2-23-2016.pdf
S.216~Jennifer Carbee, Legislative Counsel, Office of Legislative Council~Draft No. 1.2 Dated 2.17.2016~2-23-2016.pdf
S.216~Susan Barrett~Presentation on S. 216 – An act relating to prescription drug formularies~2-23-2016.pdf
W~Brian Murphy, Pharmacy Program Director, Blue Cross Blue Shield~S.216 Price A Drug Website Snapshots~2-17-2016.pdf
W~Charles Storrow, Lobbyist, Express Scripts, Inc.~S.216 45 CFR Section 156.22(d)(1)~2-17-2016.pdf
W~Devon Green, Special Counsel, Agency of Administration~2017 QHP Certification Timeline Revised 3.3.16~3-9-2016.pdf
W~Devon Green, Special Counsel, Agency of Administration~S.216 Proposed Amendment RX MOOP~3-9-2016.pdf
W~Gail Zatz, Zatz and Renfrew Consulting, on behalf of concerned organizations~MOOP letter~3-9-16.pdf
W~Jennifer Carbee, Legislative Counsel, Office of Legislative Council~S.216 Draft No 1.2 Dated 2.17.16~2-17-2016.pdf
W~Jennifer Carbee, Legislative Counsel, Office of Legislative Council~S.216 Draft No. 2.5 Dated 3.11.16~3-11-2016.pdf
W~Jill Sudhoff-Guerin, Vermont Government Relations Director, American Cancer Society Cancer Action Network, Inc.~S.216 Formulary Transparency Bill~2-16-2016.pdf
W~Jill Sudhoff-Guerin, Vermont Government Relations Director, American Cancer Society Cancer Action Network, Inc.~S.216 Testimony~2-16-2016.pdf
We use cookies so that we can provide you with the best user experience possible. Click Accept to confirm that you are happy with us to use cookies.
Accept
